Page last updated: 2024-08-26

yttrium radioisotopes and Choroid Neovascularization

yttrium radioisotopes has been researched along with Choroid Neovascularization in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Avila, MP; Carla, L; Farah, ME; Fuji, G; Nau, J; Rossi, J; Santos, A	1

Other Studies

1 other study(ies) available for yttrium radioisotopes and Choroid Neovascularization

Article	Year
Three-year safety and visual acuity results of epimacular 90 strontium/90 yttrium brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Retina (Philadelphia, Pa.), 2012, Volume: 32, Issue:1 Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Brachytherapy; Choroidal Neovascularization; Combined Modality Therapy; Feasibility Studies; Female; Humans; Macular Degeneration; Male; Middle Aged; Prospective Studies; Radiotherapy Dosage; Strontium Radioisotopes; Visual Acuity; Yttrium Radioisotopes	2012

Article

Year

Three-year safety and visual acuity results of epimacular 90 strontium/90 yttrium brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration.

Retina (Philadelphia, Pa.), 2012, Volume: 32, Issue:1

Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Brachytherapy; Choroidal Neovascularization; Combined Modality Therapy; Feasibility Studies; Female; Humans; Macular Degeneration; Male; Middle Aged; Prospective Studies; Radiotherapy Dosage; Strontium Radioisotopes; Visual Acuity; Yttrium Radioisotopes

2012